Literature DB >> 6277791

Antibody responses in humans to individual proteins of herpes simplex viruses.

S C Gilman, J J Docherty, W E Rawls.   

Abstract

Sera from 231 women were used to examine their frequency of precipitation of various herpes simplex virus type 1 and 2 (HSV-1 and HSV-2) proteins and to determine if there was a rank order of immune responsiveness of humans to these HSV antigens. Radiolabeled viral proteins were reacted with serum and immune complexes isolated with staphylococcal protein A. Individual antigens were resolved by polyacrylamide gel electrophoresis and visualized by fluorography. As a group, these sera precipitated 31 HSV-1 and 27 HSV-2 proteins. HSV-1 polypeptides with molecular weights of 133,000, 99,000, and 82,000, as well as HSV-2 polypeptides with molecular weights of 131,000 and 101,000, were precipitated by essentially all sera that contained antibodies to HSV-1 and HSV-2. When attempts were made to order the viral proteins by constructing precipitation profiles ranking the antigens in patterns according to their frequency of precipitation, it was observed that the antigens were generally not ordered. Demographic analysis of the sera suggested that the differences in the number of proteins precipitated were associated with differences in age, education, age at first marriage, and income, which collectively may reflect the frequency of exposure to the virus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6277791      PMCID: PMC350951          DOI: 10.1128/iai.34.3.880-887.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Cell-mediated immunity to herpes simplex virus in man.

Authors:  A S Russell
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

2.  Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

3.  Differential effect of 7,12-dimethylbenz(a)anthracene on infectivity of herpes simplex virus type 2.

Authors:  J J Docherty; R J Goldberg; F Rapp
Journal:  Proc Soc Exp Biol Med       Date:  1971-01

4.  Proteins specified by herpes simplex virus. VI. Viral proteins in the plasma membrane.

Authors:  J W Heine; P G Spear; B Roizman
Journal:  J Virol       Date:  1972-03       Impact factor: 5.103

5.  Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens.

Authors:  M L Martin; E L Palmer; R E Kissling
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

6.  The incidence of Herpesvirus hominis antibody in the population.

Authors:  I W Smith; J F Peutherer; F O MacCallum
Journal:  J Hyg (Lond)       Date:  1967-09

7.  Cell-mediated immunity in Herpesvirus hominis infections.

Authors:  J M Wilton; L Ivanyi; T Lehner
Journal:  Br Med J       Date:  1972-03-18

8.  Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1.

Authors:  R Duff; F Rapp
Journal:  J Virol       Date:  1973-08       Impact factor: 5.103

9.  Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2.

Authors:  R Duff; F Rapp
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

10.  Reactivity of envelope, capsid, and soluble antigens of Herpesvirus hominis types 1 and 2 in the indirect hemagglutination test.

Authors:  A F Back; N J Schmidt
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  9 in total

1.  Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies.

Authors:  D E Goade; R Bell; T Yamada; G J Mertz; S Jenison
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

2.  Isolation by high-performance liquid chromatography and partial characterization of a 57,000-dalton herpes simplex virus type 1 polypeptide.

Authors:  S Welling-Wester; T Popken-Boer; J B Wilterdink; J van Beeumen; G W Welling
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  Polypeptide specificity of the antibody response after primary and recurrent infection with bovine herpesvirus 1.

Authors:  S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

4.  Simian alphaherpesviruses and their relation to the human herpes simplex viruses.

Authors:  J K Hilliard; D Black; R Eberle
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

5.  Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.

Authors:  J Glorioso; C H Schröder; G Kumel; M Szczesiul; M Levine
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

6.  Monoclonal antibodies against three major glycoproteins of varicella-zoster virus.

Authors:  C Grose; D P Edwards; W E Friedrichs; K A Weigle; W L McGuire
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Antibody activity to herpes simplex virus in mouse Ig classes and IgG subclasses.

Authors:  R R McKendall; W Woo
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

8.  Intrauterine latent herpes simplex virus infection: I. Spontaneous abortion.

Authors:  J A Robb; K Benirschke; R Barmeyer
Journal:  Hum Pathol       Date:  1986-12       Impact factor: 3.466

9.  Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2.

Authors:  William P Halford; Joshua Geltz; Edward Gershburg
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.